REACH Archives - Insights From Our Labs to Yours

Overcoming challenges in the processes of characterization, assessment, and registration of your UVCB in Europe

by Labcorp Drug Developmentupdated on Thursday, June 3, 2021Monday, March 8, 2021

The demand under European regulations for detailed environmental risk assessment of UCVBs is challenging both the industry and regulators alike. Read on to explore the challenges and possible ways of overcoming them.

Implications of the changes in the EU General Food Law (Transparency Regulation)

by Labcorp Drug Developmentupdated on Tuesday, June 8, 2021Thursday, January 7, 2021

The revised EU GFL (Reg (EC) 2019/1381), or transparency regulation, comes into force on 27 March 2021 and sees changes in the notification of studies, submission of dossiers via IUCLID and the publication of all study reports, to name a few. Read on to find out how these changes may …

How to answer basic physical chemical questions for your chemical and agrochemical substances when test guidance changes and as regulatory standards evolve

by Labcorp Drug Developmentupdated on Monday, October 19, 2020Monday, October 19, 2020

Although most physiochemical endpoints are standard for crop and chemical active substances, selection of the right test method to assess them is critical. This blog reviews some standard endpoints and looks at the tests used, in the light of changing regulatory expectations and revised test methodologies for difficult substances.

How to prepare for the upcoming REACH restrictions on microplastic usage in Europe under Annex XV

by Labcorp Drug Developmentupdated on Monday, July 20, 2020Monday, July 20, 2020

Intentionally added microplastics (tiny solid polymer particles) are included in various chemical products. Like degraded microplastic waste, intentionally added microplastics are of concern because of their potential to impact human and animal health. Regulators worldwide are assessing how to address intentionally added microplastics, with the ECHA classifying them as equivalent …

New REACH nanomaterial requirements: what you need to do

by Labcorp Drug Developmentupdated on Tuesday, June 2, 2020Monday, February 17, 2020

The new EU nanotechnology regulation On December 3, 2018, the European Commission (EC) adopted Regulation 2018/1881, amending the existing , amending the existing Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation, to directly address nanoparticles. The nanotechnology regulation applies to any substance that might be, or might contain, a …

Understanding Annexes VII-X

by Dr. David Howes, Expert Consultant in Chemical Legislation and Chemistryupdated on Monday, June 7, 2021Wednesday, September 25, 2019

Avoiding obstacles with REACH Annexes VII-X Posted by Dr. David Howes, Expert Consultant in Chemical Legislation and Chemistry. In the EU, the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulations address the manufacturing and import of chemicals to ensure they are safe for human health and the environment. The …

REACH a Better Solution: in vitro Skin Sensitization Assays as Animal Testing Alternatives

by Darren Kidd, PhD, Chris Rothwell, BSc, Debbie Henderson, BScupdated on Wednesday, May 19, 2021Monday, February 27, 2017

REACH a Better Solution: in vitro Skin Sensitization Assays as Animal Testing Alternatives Skin sensitization testing is a major gap for many companies addressing the 2018 REACH substance registration deadline. Join us for a Q&A session with our Covance experts as we review REACH requirements and focus on a better …